Product Description
Spotlight on the new Tocilizumab 400mg/20 mL offers an unparalleled option for those seeking an advanced purchase experience in immunotherapy. This grandiose monoclonal antibody is designed for intravenous infusion, providing an immaculate, clear to opalescent solution. With a generous shelf life of 24 months and registered status by health authorities, Tocilizumab meets the highest regulatory standards. Recommended for both adults and children over 2, it addresses moderate to severe rheumatoid arthritis, cytokine release syndrome, and other inflammatory conditions with unmatched reliability.
Comprehensive Applications for Tocilizumab 400mg/20 mL
Tocilizumab 400mg/20 mL is used for the treatment of moderate to severe rheumatoid arthritis, cytokine release syndrome, and juvenile idiopathic arthritis. Application areas include immunology clinics, hospital infusion centers, and specialized healthcare facilities. The advance purchase medicine is suitable for both adults and pediatric patients aged two and above, providing targeted relief for various inflammatory conditions under the guidance of a healthcare professional.
Payments, Ports, and Market Valuation for Distribution
Estimate your procurement for Tocilizumab 400mg/20 mL efficiently, with shipments primarily departing from major FOB ports in India. Each order undergoes valuation based on volume and destination requirements, ensuring seamless process for hospitals and pharmacies. The main domestic market serves both urban and regional healthcare institutions, with products shipped securely and promptly to meet the highest quality standards in the industry.
FAQ's of Tocilizumab 400mg/ 20 mL:
Q: How is Tocilizumab 400mg/20 mL administered?
A: Tocilizumab 400mg/20 mL is administered as an intravenous (IV) infusion, typically over the course of one hour, as prescribed by a healthcare professional, based on patient weight and medical indication.
Q: What are the primary uses of Tocilizumab 400mg/20 mL?
A: This medication is mainly used for treating moderate to severe rheumatoid arthritis, cytokine release syndrome, and certain types of juvenile idiopathic arthritis in adults and children aged two years or older.
Q: When is Tocilizumab contraindicated?
A: It is contraindicated in patients with known hypersensitivity to Tocilizumab or any of its excipients and those experiencing active severe infections.
Q: Where can Tocilizumab 400mg/20 mL be obtained?
A: The product is available through multiple pharmaceutical distributors, and is supplied to hospitals, clinics, and pharmacies across the country. Prescription is required for purchase.
Q: What is the process for advance purchase and shipping?
A: Healthcare providers or procurement departments can estimate their needs, place advance purchase orders, and arrange shipping from major FOB ports in India. All orders meet regulatory and quality compliance prior to shipping.
Q: What benefits does Tocilizumab provide for patients?
A: Tocilizumab offers an effective and reliable treatment option for inflammatory conditions by blocking interleukin-6 (IL-6) receptors, thus reducing inflammation and improving patient quality of life.